Efficacy and safety of pemafibrate in patients with chronic kidney disease: A retrospective study

Hypertriglyceridemia and chronic kidney disease (CKD) are known risk factors for cardiovascular disease. However, treatment with statins, which control low-density lipoprotein cholesterol levels, increases the risk of estimated glomerular filtration rate (eGFR) reduction. Although conventional fibra...

Descripción completa

Detalles Bibliográficos
Autores principales: Iwasaki, Masako, Suzuki, Hitoshi, Umezawa, Yukako, Koshida, Takeo, Saito, Midori, Fukuda, Hiromitsu, Takahara, Hisatsugu, Matsuzaki, Keiichi, Suzuki, Yusuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
5200
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9936022/
https://www.ncbi.nlm.nih.gov/pubmed/36800602
http://dx.doi.org/10.1097/MD.0000000000032818

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9936022/
https://www.ncbi.nlm.nih.gov/pubmed/36800602
http://dx.doi.org/10.1097/MD.0000000000032818

Ejemplares similares